Carcinogenesis Advance Access originally published online on May 5, 2005
Carcinogenesis 2005 26(9):1596-1602; doi:10.1093/carcin/bgi105
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis vol.26 no.9 © Oxford University Press 2005; all rights reserved.
Genetic polymorphisms of p21 are associated with risk of squamous cell carcinoma of the head and neck
1 Department of Epidemiology and 2 Department of Head and Neck Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
* To whom correspondence should be addressed at: Department of Epidemiology, Box 189, The University of Texas, M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Tel: +1 713 792 3020; Fax: +1 713 563 0999; Email: qwei{at}mdanderson.org
The p21 (Waf1/Cip1/CDKN1A) protein regulates the transition from the G1 to the S phase and has an important role in modulating cell-cycle control, apoptosis and cell growth. Two polymorphisms of the p21 gene at codon 31 (p21 C98A, dbSNP rs1801270) and at the 3' untranslated region (p21 T70C, dbSNP rs1059234) may have an effect on the protein function and may thus play a role in the development of cancer. We hypothesized that these two p21 polymorphisms are associated with the risk of squamous cell carcinoma of the head and neck (SCCHN). We tested this hypothesis in a hospital-based case–control study of 712 patients newly diagnosed with SCCHN and 1222 cancer-free controls who were frequency-matched by age, sex and ethnicity. All subjects were non-Hispanic whites. Our results showed that the variant alleles and genotypes were more common among cases than among controls (P < 0.001 and P = 0.013 for p21C70T, and P < 0.001 and P = 0.035 for p21C98A, respectively). Compared with the p21 70CC genotype, there was a significantly greater risk of SCCHN associated with the variant p21 70TC [odds ratio (OR) = 1.47, 95% confidence interval (CI) = 1.12–1.93] and combined p21 70TC/TT (OR = 1.49, 95% CI = 1.14–1.95) genotypes. Similarly, compared with the p21 98CC genotype, there was also a significantly greater SCCHN risk associated with the variant p21 98AC (OR = 1.32, 95% CI = 1.00–1.73) and combined p21 98AC/AA (OR = 1.37, 95% CI = 1.05–1.79) genotypes. When these two polymorphisms were evaluated together by the number of risk alleles, there was a significant increase in SCCHN risk that was dependent on the number of risk alleles (Ptrend = 0.001). Our results suggest that the presence of these two p21 polymorphisms may be a marker of genetic susceptibility to SCCHN.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  P. Sun, Y. Qiu, Z. Zhang, J. Wan, T. Wang, X. Jin, Q. Lan, N. Rothman, and Z.-l. Xia Association of Genetic Polymorphisms, mRNA Expression of p53 and p21 with Chronic Benzene Poisoning in a Chinese Occupational Population Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1821 - 1828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Chen, E. M. Sturgis, A. K. El-Naggar, Q. Wei, and G. Li Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers Carcinogenesis, November 1, 2008; 29(11): 2120 - 2125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Chen, H. Zhao, Z. Hu, L.-E Wang, W. Zhang, E. M. Sturgis, and Q. Wei CASP3 Polymorphisms and Risk of Squamous Cell Carcinoma of the Head and Neck Clin. Cancer Res., October 1, 2008; 14(19): 6343 - 6349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Driver, H. Song, F. Lesueur, S. Ahmed, N. L. Barbosa-Morais, J. P. Tyrer, B. A.J. Ponder, D. F. Easton, P. D.P. Pharoah, A. M. Dunning, et al. Association of single-nucleotide polymorphisms in the cell cycle genes with breast cancer in the British population Carcinogenesis, February 1, 2008; 29(2): 333 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Chen, Z. Hu, L.-E Wang, E. M. Sturgis, A. K. El-Naggar, W. Zhang, and Q. Wei Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck Carcinogenesis, September 1, 2007; 28(9): 2008 - 2012. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Hirata, Y. Hinoda, N. Kikuno, K. Kawamoto, Y. Suehiro, Y. Tanaka, and R. Dahiya MDM2 SNP309 Polymorphism as Risk Factor for Susceptibility and Poor Prognosis in Renal Cell Carcinoma Clin. Cancer Res., July 15, 2007; 13(14): 4123 - 4129. [Abstract] [Full Text] [PDF]
|
|